As of May 27
| +0.04 / +1.72%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +281.36% increase from the last price of 2.36.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.